DECIPHERA PHARMACEUT

Item 5.07. Submission of Matters to a Vote of Security Holders.

The 2022 Annual Meeting of Stockholders (the "Annual Meeting") of Deciphera
Pharmaceuticals, Inc. (the "Company") was held on June 23, 2022. At the Annual
Meeting, there were present, in person or by proxy, holders of 52,346,970.49
shares of common stock, or approximately 89.15% of the total outstanding shares
eligible to be voted. The holders present voted on the three proposals presented
at the Annual Meeting as follows.

Proposal One - Election of Directors

The Company's stockholders approved the election of three Class II directors to
the Company's Board of Directors ("Board") by the following votes:

Nominee Votes For Votes Withheld Broker Non-Votes
Steven L. Hoerter 41,524,194.62 8,562,072.86 2,260,703
Susan L. Kelley, M.D. 39,130,107.10 10,956,160.38 2,260,703
John R. Martin 40,282,916.55 9,803,350.93 2,260,703

Proposal Two - Non-Binding Advisory Vote on the Compensation of the Company's
Named Executive Officers

The Company's stockholders approved, on a non-binding, advisory basis, the
compensation of the Company's named executive officers, as disclosed in the
proxy statement for the Annual Meeting pursuant to Section 14A of the Securities
Exchange Act of 1934, as amended, including the Compensation Discussion and
Analysis, the Summary Compensation Table, and the narrative disclosures that
accompany the compensation tables. The final votes were:

Votes For Votes Against Abstentions Broker Non-Votes
33,662,657.64 16,408,762.45 14,847.38 2,260,703

Proposal Three - Ratification of Appointment of Independent Accounting Firm

The Company's stockholders ratified the appointment of PricewaterhouseCoopers
LLP as the Company's independent registered accounting firm for the fiscal year
ending December 31, 2022 by the following votes:

Votes For Votes Against Abstentions
47,607,579.05 4,726,437.37 12,954.06

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses